Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > EV / Sales (ltm)

Rigel Pharmaceuticals EV / Sales (ltm) Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly EV / Sales (ltm) from 2010 to 2020.
  • Rigel Pharmaceuticals EV / Sales (ltm) for the quarter ending September 09, 2020 was 3.09 a -16.69% decrease of -0.52 year over year
  • Rigel Pharmaceuticals EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 3.09 a -16.69% decrease of -0.52 year over year
  • Rigel Pharmaceuticals Annual EV / Sales (ltm) for 2020 was 3.09 a -6.07% decrease of -0.19 from 2019
  • Rigel Pharmaceuticals Annual EV / Sales (ltm) for 2020 was 3.28 a -7.15% decrease of -0.23 from 2019
  • Rigel Pharmaceuticals Annual EV / Sales (ltm) for 2020 was 3.51 a -2.67% decrease of -0.09 from 2019
Other Valuation Metrics:
  • Rigel Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $521m a 35.88% increase of 187m year over year
  • Rigel Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 5.16 a 23.02% increase of 1.19 year over year
  • Rigel Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $406m a 41.78% increase of 169m year over year
View Chart On Koyfin

Quarterly RIGL EV / Sales (ltm) Data

09/20203.09
09/20203.28
09/20203.51
09/20203.61
09/20203.45
09/20203.41
09/20203.45
09/20203.19
09/20203.20
09/20203.22

Annual RIGL EV / Sales (ltm) Data

20203.09
20203.28
20203.51
20203.61
20203.45
20203.41
20203.45
20203.19
20203.20
20203.22